{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T06:03:50Z","timestamp":1771567430118,"version":"3.50.1"},"reference-count":54,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["16K20163"],"award-info":[{"award-number":["16K20163"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["19K09699"],"award-info":[{"award-number":["19K09699"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["19K11651"],"award-info":[{"award-number":["19K11651"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Because prostate cancer proliferates in an androgen-dependent manner, various inhibitors of androgen production and antagonists of the androgen receptor (AR) are used as therapeutic agents. However, the emergence of castration-resistant prostate cancer has prompted the development of additional treatment strategies. In this study, we focused on the antiprostate cancer effects of vitamin D3 and examined novel antiproliferative effects through the crosstalk with androgen signaling. In human prostate cancer LNCaP cells, homeobox C9 (HOXC9) was identified as a common regulated target gene by dihydroxytestosterone and 1\u03b1,25-dihydroxyvitamin D3, but in opposite directions. Ligand-stimulated AR and vitamin D receptor competitively shared binding sites in the HOXC9 regulatory region, but dihydroxytestosterone stimulation preferentially suppressed HOXC9 expression due to the stronger binding properties of AR and the induction of DNA methylation. Forced expression of HOXC9 inhibited androgen signaling to eliminate the androgen-dependent proliferation by associating with the AR transcription complex, in part due to interference with AR binding to some of its targets in LNCaP cells. In summary, this study provides evidence for the involvement of HOXC9 in antiproliferative effects through a regulatory mechanism mediated by a crosstalk between vitamin D receptor and AR.<\/jats:p>","DOI":"10.3390\/ijms27041962","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T15:28:18Z","timestamp":1771428498000},"page":"1962","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Androgen Signaling Represses Homeobox C9, an Inhibitor of Androgen Receptor, in Prostate Cancer Cells"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2557-0830","authenticated-orcid":false,"given":"Takao","family":"Susa","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Teikyo University School of Medicine, Tokyo 173-8605, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiki","family":"Tsuboi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Teikyo University School of Medicine, Tokyo 173-8605, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Teikyo University School of Medicine, Tokyo 173-8605, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1774-2257","authenticated-orcid":false,"given":"Miho","family":"Akimoto","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Teikyo University School of Medicine, Tokyo 173-8605, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Okudaira","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Teikyo University School of Medicine, Tokyo 173-8605, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Okinaga","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Teikyo University School of Medicine, Tokyo 173-8605, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2152-2452","authenticated-orcid":false,"given":"Masayoshi","family":"Iizuka","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Teikyo University School of Medicine, Tokyo 173-8605, Japan"},{"name":"Medical Education Center, Teikyo University School of Medicine, Tokyo 173-8605, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Okazaki","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Teikyo University School of Medicine, Tokyo 173-8605, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mimi","family":"Tamamori-Adachi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Teikyo University School of Medicine, Tokyo 173-8605, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"ref_1","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"T297","DOI":"10.1530\/ERC-17-0145","article-title":"Androgen deprivation and immunotherapy for the treatment of prostate cancer","volume":"24","author":"Gamat","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Wu, C.C., Chen, P.Y., Wang, S.W., Tsai, M.H., Wang, Y.C.L., Tai, C.L., Luo, H.L., Wang, H.J., and Chen, C.Y. (2021). Risk of Fracture During Androgen Deprivation Therapy Among Patients With Prostate Cancer: A Systematic Review and Meta-Analysis of Cohort Studies. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.652979"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1021\/acs.jmedchem.3c00442","article-title":"Non-steroidal CYP17A1 Inhibitors: Discovery and Assessment","volume":"66","author":"Wrobel","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5301\/uro.5000194","article-title":"GNRH-agonist or antagonist in the treatment of prostate cancer: A comparision based on oncological results","volume":"83","author":"Salciccia","year":"2016","journal-title":"Urologia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/endrev\/bnab002","article-title":"Hormonal Therapy for Prostate Cancer","volume":"42","author":"Desai","year":"2021","journal-title":"Endocr. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"100962","DOI":"10.1016\/j.drup.2023.100962","article-title":"Current therapy and drug resistance in metastatic castration-resistant prostate cancer","volume":"68","author":"Cai","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrurol.2015.13","article-title":"Are androgen receptor variants a substitute for the full-length receptor?","volume":"12","author":"Lu","year":"2015","journal-title":"Nat. Rev. Urol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zhang, X., Morrissey, C., Sun, S., Ketchandji, M., Nelson, P.S., True, L.D., Vakar-Lopez, F., Vessella, R.L., and Plymate, S.R. (2011). Androgen receptor variants occur frequently in castration resistant prostate cancer metastases. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0027970"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMoa1315815","article-title":"AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer","volume":"371","author":"Antonarakis","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1101\/gad.316646.118","article-title":"Signaling pathways and steroid receptors modulating estrogen receptor alpha function in breast cancer","volume":"32","author":"Siersbaek","year":"2018","journal-title":"Genes. Dev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature14583","article-title":"Progesterone receptor modulates ERalpha action in breast cancer","volume":"523","author":"Mohammed","year":"2015","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Singhal, H., Greene, M.E., Tarulli, G., Zarnke, A.L., Bourgo, R.J., Laine, M., Chang, Y.F., Ma, S., Dembo, A.G., and Raj, G.V. (2016). Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer. Sci. Adv., 2.","DOI":"10.1126\/sciadv.1501924"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1158\/0008-5472.CAN-13-0742","article-title":"Reprogramming the chromatin landscape: Interplay of the estrogen and glucocorticoid receptors at the genomic level","volume":"73","author":"Miranda","year":"2013","journal-title":"Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"7386","DOI":"10.1158\/0008-5472.CAN-08-1545","article-title":"Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase","volume":"68","author":"Gong","year":"2008","journal-title":"Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2013.11.012","article-title":"Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade","volume":"155","author":"Arora","year":"2013","journal-title":"Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1678S","DOI":"10.1093\/ajcn\/80.6.1678S","article-title":"Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease","volume":"80","author":"Holick","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PPO.0b013e3181c51ee6","article-title":"Vitamin D: Considerations in the continued development as an agent for cancer prevention and therapy","volume":"16","author":"Trump","year":"2010","journal-title":"Cancer J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1017\/S0029665108006964","article-title":"The vitamin D receptor in cancer","volume":"67","author":"Thorne","year":"2008","journal-title":"Proc. Nutr. Soc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1210\/jc.2008-2695","article-title":"Expanding roles of vitamin D","volume":"94","author":"Giovannucci","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1042\/BJ20110744","article-title":"Vitamin D and cancer: A review of molecular mechanisms","volume":"441","author":"Fleet","year":"2012","journal-title":"Biochem. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1038\/sj.onc.1207461","article-title":"Androgen signaling is required for the vitamin D-mediated growth inhibition in human prostate cancer cells","volume":"23","author":"Bao","year":"2004","journal-title":"Oncogene"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Feng, Y., Zhang, T., Wang, Y., Xie, M., Ji, X., Luo, X., Huang, W., and Xia, L. (2021). Homeobox Genes in Cancers: From Carcinogenesis to Recent Therapeutic Intervention. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.770428"},{"key":"ref_24","first-page":"163","article-title":"VCaP, a cell-based model system of human prostate cancer","volume":"15","author":"Korenchuk","year":"2001","journal-title":"In Vivo"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11626-999-0115-4","article-title":"A new human prostate carcinoma cell line, 22Rv1","volume":"35","author":"Sramkoski","year":"1999","journal-title":"In Vitro Cell Dev. Biol. Anim."},{"key":"ref_26","first-page":"16","article-title":"Establishment and characterization of a human prostatic carcinoma cell line (PC-3)","volume":"17","author":"Kaighn","year":"1979","journal-title":"Investig. Urol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/pros.10261","article-title":"Stable expression of full length human androgen receptor in PC-3 prostate cancer cells enhances sensitivity to retinoic acid but not to 1alpha,25-dihydroxyvitamin D3","volume":"56","author":"Murthy","year":"2003","journal-title":"Prostate"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nbt.3658","article-title":"Targeted DNA demethylation in vivo using dCas9-peptide repeat and scFv-TET1 catalytic domain fusions","volume":"34","author":"Morita","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Morita, S., Horii, T., Kimura, M., and Hatada, I. (2020). Synergistic Upregulation of Target Genes by TET1 and VP64 in the dCas9-SunTag Platform. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21051574"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Xu, H., Li, S., Sun, Y., Xu, L., Hong, X., Wang, Z., and Hu, H. (2021). ELOVL5-Mediated Long Chain Fatty Acid Elongation Contributes to Enzalutamide Resistance of Prostate Cancer. Cancers, 13.","DOI":"10.3390\/cancers13163957"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1158\/0008-5472.CAN-20-2511","article-title":"ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer","volume":"81","author":"Centenera","year":"2021","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"8133","DOI":"10.1158\/0008-5472.CAN-09-0775","article-title":"Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism","volume":"69","author":"Tamura","year":"2009","journal-title":"Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Wang, X., Choi, J.H., Ding, J., Yang, L., Ngoka, L.C., Lee, E.J., Zha, Y., Mao, L., Jin, B., and Ren, M. (2013). HOXC9 directly regulates distinct sets of genes to coordinate diverse cellular processes during neuronal differentiation. BMC Genomics, 14.","DOI":"10.1186\/1471-2164-14-830"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/sj.embor.7401046","article-title":"New androgen receptor genomic targets show an interaction with the ETS1 transcription factor","volume":"8","author":"Massie","year":"2007","journal-title":"EMBO Rep."},{"key":"ref_35","first-page":"23","article-title":"HOX genes: Seductive science, mysterious mechanisms","volume":"75","author":"Lappin","year":"2006","journal-title":"Ulster Med. J."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Chanda, D., Lee, J.H., Sawant, A., Hensel, J.A., Isayeva, T., Reilly, S.D., Siegal, G.P., Smith, C., Grizzle, W., and Singh, R. (2014). Anterior gradient protein-2 is a regulator of cellular adhesion in prostate cancer. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0089940"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/carcin\/bgs141","article-title":"Knockdown of AGR2 induces cellular senescence in prostate cancer cells","volume":"33","author":"Hu","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13148-015-0161-6","article-title":"Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors","volume":"7","author":"Geybels","year":"2015","journal-title":"Clin. Epigenetics"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/bj20030689","article-title":"Isolation and identification of L-dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid system","volume":"375","author":"Wafa","year":"2003","journal-title":"Biochem. J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"7938","DOI":"10.1158\/0008-5472.CAN-08-0932","article-title":"The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer","volume":"68","author":"Clark","year":"2008","journal-title":"Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"48020","DOI":"10.1074\/jbc.M209741200","article-title":"RanBPM, a nuclear protein that interacts with and regulates transcriptional activity of androgen receptor and glucocorticoid receptor","volume":"277","author":"Rao","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0006-291X(02)00564-8","article-title":"Stabilization of androgen receptor protein is induced by agonist, not by antagonists","volume":"294","author":"Furutani","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/ijc.31818","article-title":"Interference with the androgen receptor protein stability in therapy-resistant prostate cancer","volume":"144","author":"Lakshmana","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.celrep.2014.01.013","article-title":"Destruction of full-length androgen receptor by wild-type SPOP, but not prostate-cancer-associated mutants","volume":"6","author":"An","year":"2014","journal-title":"Cell Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"41311","DOI":"10.1074\/jbc.M206741200","article-title":"PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription","volume":"277","author":"Nishida","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1038\/onc.2015.292","article-title":"PIAS1 is a determinant of poor survival and acts as a positive feedback regulator of AR signaling through enhanced AR stabilization in prostate cancer","volume":"35","author":"Puhr","year":"2016","journal-title":"Oncogene"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Dahiya, U.R., and Heemers, H.V. (2022). Analyzing the Androgen Receptor Interactome in Prostate Cancer: Implications for Therapeutic Intervention. Cells, 11.","DOI":"10.3390\/cells11060936"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Sawada, T., Kanemoto, Y., Kurokawa, T., and Kato, S. (2023). The epigenetic function of androgen receptor in prostate cancer progression. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1083486"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1158\/1541-7786.MCR-10-0111","article-title":"HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes","volume":"8","author":"Axlund","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"R219","DOI":"10.1530\/ERC-15-0556","article-title":"Androgen control of lipid metabolism in prostate cancer: Novel insights and future applications","volume":"23","author":"Butler","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Scaglia, N., Frontini-Lopez, Y.R., and Zadra, G. (2021). Prostate Cancer Progression: As a Matter of Fats. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.719865"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/jcp.24906","article-title":"Wild-type and specific mutant androgen receptor mediates transcription via 17beta-estradiol in sex hormone-sensitive cancer cells","volume":"230","author":"Susa","year":"2015","journal-title":"J. Cell Physiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"9024","DOI":"10.1038\/s41598-018-27441-x","article-title":"Without 1alpha-hydroxylation, the gene expression profile of 25(OH)D3 treatment overlaps deeply with that of 1,25(OH)2D3 in prostate cancer cells","volume":"8","author":"Susa","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"105593","DOI":"10.1016\/j.jsbmb.2020.105593","article-title":"25(OH)D3 stimulates the expression of vitamin D target genes in renal tubular cells when Cyp27b1 is abrogated","volume":"199","author":"Kikuyama","year":"2020","journal-title":"J. Steroid Biochem. Mol. Biol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/4\/1962\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T05:19:50Z","timestamp":1771564790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/4\/1962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":54,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["ijms27041962"],"URL":"https:\/\/doi.org\/10.3390\/ijms27041962","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]}}}